TrialReader


Trans-tarsal Stair-step Lateral Extension of the Transconjunctival Approach

NCT07044258 — Not applicable, Completed, 20 participants, Alexandria University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Trans-tarsal Stair-step Lateral Extension of the Transconjunctival Approach Versus Transconjunctival Approach in the Management of Orbito-zygomaticomaxillary Complex Fractures (Randomized Controlled Clinical Trial)

RegistryNCT07044258
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, treatment
Enrollment20 (Actual)
SponsorAlexandria University (Other)
ConditionsZygomatic Fractures, Lower Eyelid Entropion
Interventionstrans-tarsal stair-step lateral extension of the transconjunctival approach, transconjunctival approach (Procedure)
Datesstart 2024-10-01, primary completion 2025-03-30, completion 2025-06-15, first posted 2025-06-29, last updated 2025-06-29
Locations1 site in Egypt

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Zygomatic Fractures All trials for Lower Eyelid Entropion All trials of trans-tarsal stair-step lateral extension of the transconjunctival approach All trials of transconjunctival approach

-Summary

Open reduction and internal fixation of orbito-zygomaticomaxillary complex (OMC) fractures has challenging impact on the selection of suitable surgical approach to orbital and zygomatic skeleton. Precise repair of the OMC fractures needs a quite understanding of the regional anatomy, precise diagnosis, an accessible exposure and an accurate rigid fixation of fracture to restore the normal form. The esthetic results are one of the most important requirements for this incision in the facial fracture reduction. conventional approaches to the infraorbital rim/orbital floor include (subciliary mid lower eyelid, or subtarsal) and infraorbital incisions. A thorough understanding of each incisional technique requires an appreciation of the relevant anatomy putting in considerations the risk of associated complications. Transconjuctival incision has a lot of advantages, among which is the production of non-visible scar with low incidence of post -operative ectropion and limited access. Trans-tarsal stair-step lateral extension of the transconjunctival approach provides excellent surgical exposure of OMC fractures avoiding the use of a second incision in the area of zygomatic frontal suture. This technique provides good exposure and excellent esthetics.

the aim of this study is to compare Trans-tarsal Stair-Step Lateral Extension of the Transconjunctival approach with transconjunctival approach in the management of orbital and zygomaticomaxillary complex fractures.

Expand all sections  ·  Collapse all

+Detailed description

This study will be made on twenty patients who will undergo fracture repair of the zygomaticomaxillary complex. Post- operative patient evaluation will be performed with specific attention paid towards accessibility, the exposure duration (time from incision till exposure of the field), esthetic appearance, post- operative pain, postoperative edema, orbital movement, wound healing, scarring, infra orbital nerve sensation and the post- operative ocular complications such as ectropion, entropion, enophthalmos, scleral show and corneal abrasion. Post- operative clinical examinations along with radiographic examination will be done to evaluate the position of zygoma and determine the adequacy of fracture reduction.

+Arms and interventions

ArmTypeInterventionsDescription
trans-tarsal stair-step lateral extension of the transconjunctival approachActive comparatorProcedure: trans-tarsal stair-step lateral extension of the transconjunctival approachpatients presented with oribto-zygomaticomaxillary complex fractures that requires open reduction and internal fixation via trans-tarsal stair-step lateral extension of the transconjunctival approach
transconjunctival approachExperimentalProcedure: transconjunctival approachpatients presented with oribto-zygomaticomaxillary complex fractures that requires open reduction and internal fixation via transconjunctival approach
  • trans-tarsal stair-step lateral extension of the transconjunctival approach (Procedure): patients presented with oribto-zygomaticomaxillary complex fractures that requires open reduction and internal fixation via trans-tarsal stair-step lateral extension of the transconjunctival approach
  • transconjunctival approach (Procedure): patients presented with oribto-zygomaticomaxillary complex fractures that requires open reduction and internal fixation via trans-tarsal stair-step lateral extension of the transconjunctival approach

+Outcome measures

Primary outcomes

  • exposure duration [During the surgery]: The time taken between performing the incision till exposure of the field will be recorded using a stopwatch.

Secondary outcomes

  • postoperative edema [1.5 month]: The postoperative edema will be categorized subjectively into mild (just noticeable), mild to moderate (more obvious edema without occlusion of palpebral fissure), moderate to severe (edema partially occluding palpebral fissure), and severe (edema totally occluding palpebral fissure).

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

1. Patients with OMC fractures that require open reduction with internal fixation.
2. Patients with orbital wall defects.
3. Patients with blow out fractures.
4. Adult patient between 18 and 60 years with no gender predilections.

Exclusion Criteria:

1. Existing lacerations in the inferior and lateral periorbital regions.
2. Comminuted fracture with bone loss.
3. Existence of infection at the fracture line.
4. Presence of acute or chronic conjunctival diseases.

+Locations (1)

FacilityCityCountryStatus
Faculty of Dentistry, Alexandria UniversityAlexandria, Alexandria GovernorateEgypt

+Publications

  • Results publication: Sobhy DE, Dessoky NY, Alryess AM, Noureldin MG. Trans-tarsal stair-step versus transconjunctival approach in orbito-zygomaticomaxillary fractures: a prospective randomized controlled clinical trial. BMC Oral Health. 2026 Jun 17;26(1):1069. doi: 10.1186/s12903-026-08842-1. PMID 42304401

My Notes